Biodexa Pharmaceuticals Plc (BDRX) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Biodexa Pharmaceuticals Plc (BDRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $544,662, listed on NASDAQ, employing roughly 11 people, carrying a beta of 1.19 to the broader market. Biodexa Pharmaceuticals Plc, a biopharmaceutical company in the clinical development stage, is dedicated to advancing a diverse portfolio of products. Led by Stephen Anthony Stamp, public since 2015-12-07.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for BDRX as of 2026-09-22; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →